The interaction between PD-L1 and PD-1 on anti-tumor CD8 T cells results in a signaling process that leads to reduced T cell function and T cell exhaustion as well as reduction in the synthesis of inflammatory cytokines [30]. The gene discussed is CD8A; the disease is neoplasm.